Evolução do estado nutricional na doença de Gaucher tipo I em tratamento com reposição enzimática - relato de dois casos

Coradine, Andréa Vieira Pereira; Pianovski, Mara Albonei Dudeque.
Rev. bras. saúde matern. infant ; 15(2): 231-234, Apr-Jun/2015. tab
Artigo em Português | LILACS, BVSAM | ID: lil-753161

Documentos relacionados

  1. Pancreatic exocrine insufficiency after non-pancreatic upper gastrointestinal surgery: meta-analysis.
  2. Findings from the Morquio A Registry Study (MARS) after 6 years: Long-term outcomes of MPS IVA patients treated with elosulfase alfa.
  3. Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations.
  4. Perioperative management of pancreatic exocrine insufficiency-evidence-based proposal for a paradigm shift in pancreatic surgery.
  5. Effectiveness and Safety of Eliglustat Treatment in Gaucher Disease: Real-life Unicentric Experience.
  6. Modifying enzyme replacement therapy - A perspective.
  7. Management of hypersensitivity reactions to enzyme replacement therapy in children with lysosomal storage diseases.
  8. Clinical relevance of globotriaosylceramide accumulation in Fabry disease and the effect of agalsidase beta in affected tissues.
  9. Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States.
  10. Pregnancy and associated events in women receiving enzyme replacement therapy for late-onset glycogen storage disease type II (Pompe disease).